Although both loss- and gain-of-function disease mechanisms have been proposed in C9-ALS/FTD (5, 49), the transport impairment in our patient-derived motor neurons was not associated with a reduction in overall C9orf72 mRNA and protein levels. The gene discussed is C9; the disease is frontotemporal dementia.